Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.4M Buy
481,715
+435,715
+947% +$44.4M 1.38% 26
2025
Q4
$4.63M Sell
46,000
-1,054,000
-96% -$104M 0.16% 63
2025
Q3
$95.1M Buy
1,100,000
+25,000
+2% +$1.98M 4.3% 3
2025
Q2
$82M Hold
1,075,000
4.32% 4
2025
Q1
$76.2M Buy
1,075,000
+475,000
+79% +$37.1M 5.44% 4
2024
Q4
$47M Buy
+600,000
New +$56M 2.78% 10
2024
Q1
Sell
-200,000
Closed -$14.7M 67
2023
Q4
$14.7M Buy
+200,000
New +$12.4M 1.56% 23

Other funds holding NUVL

Vestal Point Capital's NUVL Position: Q1 2026 in Review

Vestal Point Capital increased its Nuvalent (NUVL) stake by 947% in Q1 2026, buying an estimated $44.4M and bringing the position to 481,715 shares worth $49.4M. The position accounts for 1.38% of the portfolio, ranked #26.

Vestal Point Capital first reported a position in NUVL in Q4 2023 and has held it in 7 quarters since. The position peaked at $95.1M in Q3 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Vestal Point Capital held 481,715 shares of Nuvalent worth $49.4M as of Q1 2026.
  • Vestal Point Capital bought 435,715 Nuvalent shares in Q1 2026, an estimated $44.4M.
  • Nuvalent made up 1.38% of Vestal Point Capital's portfolio in Q1 2026, its #26 holding.
  • Vestal Point Capital first reported a position in Nuvalent in Q4 2023 and has held it in 7 quarters since.
  • Vestal Point Capital's Nuvalent position peaked at $95.1M in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.